| Primary |
|
|
| Secondary |
| Product Used For Unknown Indication |
39.7% |
| Schizophrenia |
8.0% |
| Psychotic Disorder |
7.2% |
| Agitation |
6.5% |
| Foetal Exposure During Pregnancy |
6.3% |
| Schizophrenia, Paranoid Type |
4.9% |
| Depression |
3.6% |
| Drug Use For Unknown Indication |
3.6% |
| Insomnia |
3.1% |
| Bipolar Disorder |
2.5% |
| Pneumonia |
2.2% |
| Epilepsy |
2.0% |
| Maternal Exposure Timing Unspecified |
1.8% |
| Infection Prophylaxis |
1.4% |
| Mania |
1.4% |
| Anxiety |
1.3% |
| Laxative Supportive Care |
1.3% |
| Drug Exposure During Pregnancy |
1.1% |
| Ill-defined Disorder |
1.1% |
| Affective Disorder |
0.9% |
|
| Electrocardiogram Qt Prolonged |
24.7% |
| Septic Shock |
7.4% |
| Sinus Tachycardia |
7.4% |
| Coma |
4.9% |
| Incorrect Dose Administered |
4.9% |
| Myocardial Infarction |
4.9% |
| Somnolence |
4.9% |
| Sudden Death |
4.9% |
| Tardive Dyskinesia |
4.9% |
| Bundle Branch Block Right |
3.7% |
| Colitis Ischaemic |
3.7% |
| Pyrexia |
3.7% |
| Cardiac Arrest |
2.5% |
| Cholestasis |
2.5% |
| Femoral Neck Fracture |
2.5% |
| Hypokalaemia |
2.5% |
| Intestinal Obstruction |
2.5% |
| Leukopenia |
2.5% |
| Neutropenia |
2.5% |
| Placental Infarction |
2.5% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.9% |
| Agitation |
11.0% |
| Psychotic Disorder |
9.2% |
| Schizophrenia |
8.8% |
| Drug Use For Unknown Indication |
6.5% |
| Bipolar Disorder |
6.1% |
| Parkinson's Disease |
5.9% |
| Schizoaffective Disorder |
4.3% |
| Anxiety |
4.1% |
| Depression |
3.5% |
| Childhood Psychosis |
2.9% |
| Constipation |
2.5% |
| Schizophrenia, Paranoid Type |
2.5% |
| Abnormal Behaviour |
2.0% |
| Chronic Obstructive Pulmonary Disease |
2.0% |
| Pain |
2.0% |
| Dystonia |
1.6% |
| Pyrexia |
1.6% |
| Affective Disorder |
1.2% |
| Chronic Lymphocytic Leukaemia |
1.2% |
|
| Neutropenia |
12.5% |
| Death |
10.0% |
| Pulmonary Embolism |
8.8% |
| Tricuspid Valve Incompetence |
7.5% |
| Diabetes Mellitus |
6.3% |
| Cardiac Arrest |
5.0% |
| Non-obstructive Cardiomyopathy |
5.0% |
| Renal Failure |
5.0% |
| Anxiety |
3.8% |
| C-reactive Protein Increased |
3.8% |
| Dizziness |
3.8% |
| Fall |
3.8% |
| Gamma-glutamyltransferase Increased |
3.8% |
| Leukopenia |
3.8% |
| Suicide Attempt |
3.8% |
| Weight Increased |
3.8% |
| Alanine Aminotransferase Increased |
2.5% |
| Aspartate Aminotransferase Increased |
2.5% |
| Cytolytic Hepatitis |
2.5% |
| Depression |
2.5% |
|
| Interacting |
| Depression |
29.0% |
| Psychotic Disorder |
17.4% |
| Bipolar Disorder |
14.5% |
| Hyperglycaemia |
14.5% |
| Thyroid Disorder |
14.5% |
| Atrial Fibrillation |
2.9% |
| Drug Use For Unknown Indication |
2.9% |
| Extrapyramidal Disorder |
1.4% |
| Hypersensitivity |
1.4% |
| Hypertension |
1.4% |
|
| Drug Interaction |
41.7% |
| Urinary Retention |
33.3% |
| Suicidal Ideation |
16.7% |
| Femoral Neck Fracture |
8.3% |
|
